Emery Pharma

Executive Summary

Emery Pharma is a full-service Contract Research Organization (CRO) headquartered in Alameda, California, and founded in 2012. The company specializes in customized analytical, bioanalytical, and microbiology services tailored to small molecules and biologics, operating under strict GLP/cGMP compliance. Its offerings also include consulting and litigation support, positioning it as a versatile partner for life science innovators. As a private company, Emery Pharma has not disclosed funding rounds or valuation, but its long-standing presence and compliance capabilities indicate a stable, niche market position within the competitive CRO landscape. The firm's focus on quality and regulatory adherence makes it a reliable partner for drug developers seeking outsourced expertise, though its growth trajectory may be limited by the broader CRO market dynamics and its private ownership.

Upcoming Catalysts (preview)

• TBDExpansion into biologics and large-molecule analytical services70% success
• TBDStrategic partnership or acquisition by a larger CRO30% success
• TBDNew laboratory facility or service line launch50% success